Marbury Law Again Ranked in Top Ten By PatentBots for 2022

Marbury Law Group was once again ranked in the top ten for PatentBots’ quality scores for U.S. Patent and Trademark Office Technology Center 2800 (Semiconductors/Memory, Circuit/Measuring and Testing, Optics/Photocopying, Printing/Measuring and Testing). Patent Bots Automated Proofreading and Examiner Statistics Blog

2022-09-02T11:51:53-05:00September 2, 2022|Firm News|

Sunday, September 18th, 2022 – “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case” discussion

Marbury Partner Michelle E. O’Brien will discuss the latest updates on “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case” at IPO’s Annual Meeting in Los Angeles, CA on September 18, 2022.

2022-09-02T00:33:56-05:00September 2, 2022|Firm News|

Thursday, August 4, 2022 – “The Teva Petition for Certiorari in GSK v. Teva, the COREG® case”

Marbury partner Michelle E. O'Brien will co-present "The Teva Petition for Certiorari in GSK v. Teva, the COREG® case" at IPO's Pharma/Bio Monthly Meeting on August 4, 2022.

2022-08-03T16:24:06-05:00August 2, 2022|Firm News|

Kansas State Bar Association’s 2022 Intellectual Property Institute “Patent Year in Review” – Friday June 3, 2022

Marbury Partner Michelle E. O’Brien will be joining an expert panel of patent practitioners at the Kansas State Bar Association’s 2022 Intellectual Property Institute on Friday, June 3, 2022.  The panel, “Patent Year in Review,” will discuss the impact of recent important decisions by the U.S. Supreme Court, Court of Appeals for the Federal Circuit, and U.S. [...]

2022-06-02T16:05:34-05:00June 2, 2022|Firm News|

Friday, May 20, 2022 – Advanced Chemical/Pharma Patent Practice Institute: A Post Doc Bootcamp

Marbury Partner Michelle E. O’Brien will be joining a distinguished group of experienced chemical and pharmaceutical patent practitioners at the Advanced Chemical/Pharma Patent Practice Institute: A Post Doc Bootcamp on Friday, May 20, 2022, following the close of the AIPLA Spring Meeting.  Michelle and her colleagues will present an interactive, 3 hour program focused on [...]

2022-04-19T17:33:59-05:00April 18, 2022|Firm News|

Tuesday, May 17, 2022 – Chemical Patent Language Workshop: The Global Quest for Reasonable Certainty

Marbury Partner Michelle E. O’Brien will be joining an expert panel of patent practitioners at AIPLA’s Spring Meeting on Tuesday, May 17, 2022, to discuss Chemical Patent Language Workshop: The Global Quest for Reasonable Certainty.  The panel will consider various claim language and discuss how it has been or may be construed by courts, with [...]

2022-04-19T17:33:30-05:00April 18, 2022|Firm News|

Marbury Law Ranked in the Top Ten for PatentBots Quality Scores

Marbury Law ranked in the Top Ten of this year’s PatentBots’ quality scores for U.S. Patent and Trademark Office Technology Center 2800.  The ranking was based on a review of 284 firms with at least 50 issued patents in the areas examined by Technology Center 2800 (Semiconductors/Memory, Circuit/Measuring and Testing, Optics/Photocopying, Printing/Measuring and Testing). https://www.patentbots.com/firms/2800

2020-06-09T13:10:55-05:00June 9, 2020|Firm News, Uncategorized|

Marbury Named among Top Patent Firms for 2018

Marbury Law is ranked #189 of 722 patent firms. The Harrity Analytics Team compiled a list of the top patent law firms based upon the number of U.S. utility patents issued in 2018 where a minimum of 50 utility patents was obtained by the firm. Marbury obtained 341 patents for its clients in 2018. https://harrityllp.com/services/patent-analytics/top-patent-firms-2018/

2019-07-01T13:50:03-05:00June 22, 2019|Firm News|

Partner Michelle O’Brien To Speak At 10th Annual Crystal Forms Conference

Marbury partner Michelle O’Brien is lecturing on U.S. Patent Protection of Solid Forms at the 10th Annual Crystal Forms conference at the University of Bologna in Italy.  Her lecture will focus on how the U.S. Patent Office and U.S. courts treat patents for new solid forms of chemical compounds, with an emphasis on pharmaceutical compounds. [...]

2019-06-10T12:52:27-05:00June 10, 2019|Firm News|
Go to Top